Overview

Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
0
Participant gender:
All
Summary
Assess the impact in outcome of the use of zoledronic acid in multiple myeloma.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Instituto Mexicano del Seguro Social
Treatments:
Diphosphonates
Zoledronic Acid
Criteria
Inclusion Criteria:

Diagnosis of multiple myeloma No previous treatment Symptomatic High risk (ISS) or stage
III ( Durie-Salmon) No severe comorbidities -

Exclusion Criteria:

Pregnancy HIV + Refuse treatment

-